NCT01666210View on ClinicalTrials.gov

Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Ocular Inflammation and Pain
Interventions
DRUG

OTX-DP (Dexamethasone punctum plug)

Sustained and tapered release of dexamethasone from hydrogel punctum plug

DRUG

Placebo Vehicle Punctum Plug

Hydrogel punctum plug without dexamethasone

Trial Locations (1)

60169

Chicago Cornea Consultants, Ltd., Hoffman Estates

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY